[Special Stock] Shinpung Pharmaceutical Falls 11% on News of Partial Sale of Major Shareholder Stake
[Asia Economy Reporter Jang Hyowon] Shinpoong Pharmaceutical is experiencing a sharp decline following news that its largest shareholder sold part of its stake.
As of 10:06 AM on the 27th, Shinpoong Pharmaceutical is trading at 83,400 KRW, down 11.65% from the previous day.
On this day, Shinpoong Pharmaceutical's largest shareholder, 'Songamsa,' sold 2 million shares (3.63%) at 84,016 KRW per share in an off-hours transaction. The disposal amount was 168 billion KRW. As a result, Songamsa's stake decreased from 26.86% to 23.23%.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- "Hancom Breaks Away from Its 36-Year Mission and Formula for Success" (Comprehensive)
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
The largest shareholder of Songamsa is Jang Wonjun, CEO of Shinpoong Pharmaceutical, who holds 72.91% of the shares. CEO Jang also owns 0.19% of Shinpoong Pharmaceutical's common stock and 5.12% of preferred stock.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
